Publications by authors named "Rachel Craven"

Claim this Profile
P
Postoperative Prescribing Practices Following Gynecologic Surgery.
Rachel J Craven, Madeline K Moureau, Heidi W Brown, Emily M Buttigieg

WMJ· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.
Nick Hornigold, Karen R Dunn, Rachel A Craven, Alexandre Zougman, Sebastian Trainor

Br J Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time, verbs, and imagining events.
Jeffrey P Hong, Todd R Ferretti, Rachel Craven, Rachelle D Hepburn

Can J Exp Psychol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis.
Sophie Hepburn, David A Cairns, David Jackson, Rachel A Craven, Beverley Riley

Proteomics Clin Appl· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers and response to bevacizumab--response.
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, David A Cairns, Zougman Alexandre

Clin Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancer.
Vassilis Aggelis, Rachel A Craven, Jianhe Peng, Patricia Harnden, Lana Schaffer

Int J Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
Fiona Collinson, Michelle Hutchinson, Rachel A Craven, David A Cairns, Alexandre Zougman

Clin Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age.
Rachel A Craven, David A Cairns, Alexandre Zougman, Patricia Harnden, Peter J Selby

Proteomics Clin Appl· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissue.
Seonaid M Thompson, Rachel A Craven, Niroshini J Nirmalan, Patricia Harnden, Peter J Selby

Proteomics Clin Appl· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics and the search for biomarkers for renal cancer.
Rachel A Craven, Naveen S Vasudev, Rosamonde E Banks

Clin Biochem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma.
Claire Taylor, Rachel A Craven, Patricia Harnden, Peter J Selby, Rosamonde E Banks

Int J Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shotgun proteomics of human bile in hilar cholangiocarcinoma.
Shahid G Farid, Rachel A Craven, Jianhe Peng, Glenn K Bonney, David N Perkins

Proteomics· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosis.
Nick Hornigold, Rachel A Craven, Jeff N Keen, Tim Johnson, Rosamonde E Banks

Kidney Int· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma.
Alison C Young, Rachel A Craven, Dena Cohen, Claire Taylor, Christopher Booth

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model.
Vassilis Aggelis, Rachel A Craven, Jianhe Peng, Patricia Harnden, David A Cairns

Proteomics· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and managing renal cell carcinoma: can proteomic studies contribute to clinical practice?
Rachel A Craven, Rosamonde E Banks

Contrib Nephrol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating markers of biliary malignancy: opportunities in proteomics?
Glenn K Bonney, Rachel A Craven, Raj Prasad, Alan F Melcher, Peter J Selby

Lancet Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Key clinical issues in renal cancer: a challenge for proteomics.
Rosamonde E Banks, Rachel A Craven, Patricia Harnden, Sanjeev Madaan, Adrian Joyce

World J Urol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
David Jackson, Rachel A Craven, Richard C Hutson, Ina Graze, Paul Lueth

Clin Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic evaluation of pathways associated with dexamethasone-mediated apoptosis and resistance in multiple myeloma.
Karen S Rees-Unwin, Rachel A Craven, Emma Davenport, Sarah Hanrahan, Nicholas F Totty

Br J Haematol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S. pombe CLASP needs dynein, not EB1 or CLIP170, to induce microtubule instability and slows polymerization rates at cell tips in a dynein-dependent manner.
Agnes Grallert, Christoph Beuter, Rachel A Craven, Steve Bagley, Deepti Wilks

Genes Dev· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma.
Rachel A Craven, Sarah Hanrahan, Nick Totty, Patricia Harnden, Anthea J Stanley

Proteomics· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
Rachel A Craven, Anthea J Stanley, Sarah Hanrahan, James Dods, Richard Unwin

Proteomics· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry.
Rainy Mears, Rachel A Craven, Sarah Hanrahan, Nick Totty, Carol Upton

Proteomics· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laser capture microdissection for proteome analysis.
Rachel A Craven, Rosamonde E Banks

Curr Protoc Protein Sci· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis